Inventor · disambiguated record
Tariq M. Rana
Also filed as: RANA TARIQ M
20 granted patents·19 pending applications·450 citations·filing 1992–2021
94Inventor score
Files withUNIV MASSACHUSETTS10UNIV NEW JERSEY MED8RANA TARIQ M6UNIV CALIFORNIA5SANFORD BURNHAM MED RES INST2
Top patents by PatentIndex Score
39 records- 0198US6503713B1Methods for identifying RNA binding compoundsUNIV NEW JERSEY MED·Filed 2000·Granted Jan 7, 2003·278 cites·50 claims
- 0293US6875736B2Methods for identifying RNA binding compoundsUNIV NEW JERSEY MED·Filed 2002·Granted Apr 5, 2005·44 cites·4 claims
- 0389US9012623B2In vivo gene silencing by chemically modified and stable siRNARANA TARIQ M·Filed 2012·Granted Apr 21, 2015·6 cites·9 claims
- 0487US7951784B2RNA interference agents for therapeutic useUNIV MASSACHUSETTS·Filed 2007·Granted May 31, 2011·12 cites·1 claims
- 0583US9878050B2Delivery of agents using interfering nanoparticlesSANFORD-BURNHAM MEDICAL RES INSTITUTE·Filed 2016·Granted Jan 30, 2018·2 cites·21 claims
- 0683US9526693B2Delivery of agents using interfering nanoparticlesRANA TARIQ M·Filed 2011·Granted Dec 27, 2016·3 cites·12 claims
- 0783US7056656B1Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNAUNIV NEW JERSEY MED·Filed 2000·Granted Jun 6, 2006·34 cites·13 claims
- 0883US6583309B1Ureas and compositions thereof for treating cancer, inflammation, or a viral infectionUNIV NEW JERSEY MED·Filed 2002·Granted Jun 24, 2003·14 cites·8 claims
- 0976US2022112494A1IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE siRNAUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 1070US6420591B1Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infectionUNIV NEW JERSEY MED·Filed 2000·Granted Jul 16, 2002·3 cites·15 claims
- 1167US11136578B2In vivo gene silencing by chemically modified and stable siRNAUNIV MASSACHUSETTS·Filed 2018·Granted Oct 5, 2021·0 cites·12 claims
- 1266US7029846B2Site-specific protein modificationUNIV NEW JERSEY MED·Filed 2001·Granted Apr 18, 2006·1 cites·11 claims
- 1364US9957484B2Methods for promoting cell reprogrammingSANFORD BURNHAM MED RES INST·Filed 2014·Granted May 1, 2018·0 cites·9 claims
- 1463US5637759AMetal-ligating amino acid derivatives for MRI and for peptide synthesisUNIV CALIFORNIA·Filed 1992·Granted Jun 10, 1997·32 cites·13 claims
- 1563US2005020521A1In vivo gene silencing by chemically modified and stable siRNAUNIV MASSACHUSETTS·Filed 2003·Application pending·0 cites
- 1660US5843995AInhibition of HIV-1 replication using oligocarbamate derivativesUNIV NEW JERSEY MED·Filed 1997·Granted Dec 1, 1998·18 cites·21 claims
- 1759US10087441B2In vivo gene silencing by chemically modified and stable siRNAUNIV MASSACHUSETTS·Filed 2015·Granted Oct 2, 2018·0 cites·28 claims
- 1858US2004204377A1Delivery of siRNAsUNIV MASSACHUSETTS·Filed 2003·Application pending·0 cites
- 1957US2005221368A1Methods for identifying RNA binding compoundsUNIV NEW JERSEY MED·Filed 2005·Application pending·0 cites
- 2054US8329681B2Methods and compositions for the efficient delivery of therapeutic agents to cells and animalsRANA TARIQ M·Filed 2006·Granted Dec 11, 2012·0 cites·6 claims
- 2153US7754773B2Composition and synthesis of new reagents for inhibition of HIV replicationUNIV MASSACHUSETTS·Filed 2006·Granted Jul 13, 2010·0 cites·17 claims
- 2253US2023322715A1Broad spectrum anti-cancer compoundsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2352US2004204420A1Compounds for modulating RNA interferenceFiled 2003·Application pending·0 cites
- 2451US2013064799A1Methods for promoting cell reprogrammingRANA TARIQ M·Filed 2012·Application pending·0 cites
- 2551US2004175732A1Identification of micrornas and their targetsFiled 2003·Application pending·0 cites
- 2650US2004152651A1Regulation of transcription elongation factorsFiled 2003·Application pending·0 cites
- 2748US2005123906A1Protein modulationFiled 2004·Application pending·0 cites
- 2847US2019262371A1Methods and composition for the treatment of rna viral infectionsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 2947US2011086425A1DELIVERY OF siRNAsRANA TARIQ M·Filed 2010·Application pending·0 cites
- 3047US2005064470A1High throughput screening methods for identifying RNA binding compoundsFiled 2004·Application pending·0 cites
- 3147US2021052621A1Methods for treating flaviviruses and zika infectionsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 3245US9410128B2Method and compounds for generation of iPSCsRANA TARIQ M·Filed 2012·Granted Aug 9, 2016·0 cites·12 claims
- 3343US2004214198A1Allele-targeted RNA interferenceUNIV MASSACHUSETTS·Filed 2003·Application pending·0 cites
- 3443US2006069050A1Methods and compositions for mediating gene silencingUNIV MASSACHUSETTS·Filed 2005·Application pending·0 cites
- 3543US2005273868A1Methods and compositions for enhancing RISC activity in vitro and in vivoUNIV MASSACHUSETTS·Filed 2005·Application pending·0 cites
- 3641US2011189137A1Method for generation and regulation of ips cells and compositions thereofSANFORD BURNHAM MED RES INST·Filed 2010·Application pending·0 cites
- 3740US11136301B2Broad spectrum antiviral compounds and uses thereofUNIV CALIFORNIA·Filed 2016·Granted Oct 5, 2021·0 cites·16 claims
- 3840US6468969B1Inhibition of HIV-1 replication using d-amino acid peptidesFiled 1999·Granted Oct 22, 2002·3 cites·5 claims
- 3936US2011178092A1HIV-1 Protease InhibitorsALI AKBAR·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →